Fact CheckerSign in

NCT05800470Recruiting

The Effects of fNIRS-based Neurofeedback Training on Balance and Gait in Parkinson's Disease

The Novel Application of fNIRS-based Neurofeedback to Enhance Effects of Motor Imagery on Balance and Gait Performance in Individuals With Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 7 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

A cross-sectional study (part 1) aims to investigate the influence of fatigue on the MI ability in PD compared to healthy controls. A randomized controlled trial (part 2) aims to compare the effect of fNIRS-based NFB-MI on balance and gait performance versus MI only in people with PD.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
93 (estimated)
First submitted
22 Feb 2023
Start date
19 Mar 2025
Primary completion date
1 Aug 2025
Lead sponsor
National Yang Ming Chiao Tung University
NCT number
NCT05800470

What you commit to

  • Study type: Interventional
  • Planned participants: 93
  • From 19 Mar 2025 to the primary completion date, 1 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • using central nervous system medications other than for PD, e.g. antiepileptic drugs in recent 3 months.
    • Part 2
  • using central nervous system medications other than for PD, e.g. antiepileptic drugs in recent 3 months.

Other illness

  • cognitive impairment indicated by MMSE score \< 24;
  • history of diseases or conditions known to interfere with participating this study (e.g. epilepsy, metal implants in the brain, or deep brain stimulation);
  • diagnosis of any other neurological disease or psychiatric disorder (e.g. stroke, anxiety disorder, or depression);
  • cognitive impairment indicated by MMSE score \< 24;
  • history of diseases or conditions known to interfere with participating this study (e.g. epilepsy, metal implants in the brain, or deep brain stimulation);
  • diagnosis of any other neurological disease or psychiatric disorder (e.g. stroke, anxiety disorder, or depression);

Other

  • motor imagery ability indicated by KVIQ score \< 25;
  • unable recognize 26 letters in the English alphabet

Who the study is looking for

  • aged 40-85 y/o;
  • diagnosis of idiopathic PD by neurologist with Hoehn and Yahr stage \< 4;
  • stable medical condition;
  • capability of walking independently for 10 minutes, which is the time needed for imagery walking training in order to eliminate the possible influence of physical fatigue.

Criteria the registry did not label

  • Part 1
  • Additional Inclusion Criteria for PD:
  • diagnosis of idiopathic PD by neurologist with Hoehn and Yahr stage \< 4;
  • stable medical condition;
  • capability of walking independently without walking devices.

Age in the registry: 40 years to 85 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
National Yang Ming Chiao Tung University
Coordinator of this site? Confirm its status
TaipeiTaiwanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.